News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ironwood Pharmaceuticals Chief Executive Breaks Silence on IPO


3/29/2010 7:12:35 AM

Xconomy.Com -- Peter Hecht is finally able to speak about Ironwood Pharmaceuticals Inc.’s landmark initial public offering, breaking the silence required under quiet-period rules. The Cambridge company’s chief executive gave Xconomy a front-row perspective.

Read at Boston Globe

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES